Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Chronic Heart Failure

  Free Subscription


Articles published in J Cardiol

Retrieve available abstracts of 98 articles:
HTML format



Single Articles


    June 2022
  1. YOKOYAMA Y, Kataoka N, Nakai M, Matsuo A, et al
    A new biomarker of cardiac resynchronization therapy response: cGMP to mature BNP ratio.
    J Cardiol. 2022;79:727-733.
    PubMed     Abstract available


  2. NODA T, Lu X, Ishiguro Y, Ikuemonisan J, et al
    Cost-effective analysis of automated programming optimization in cardiac resynchronization therapy: Holistic Markov modelling.
    J Cardiol. 2022;79:734-739.
    PubMed     Abstract available


  3. KIUCHI S, Ikeda T
    Management of hypertension associated with cardiovascular failure.
    J Cardiol. 2022;79:698-702.
    PubMed     Abstract available


    April 2022
  4. AMIOKA N, Takaishi A, Nakamura K, Endo T, et al
    Innovative clinical pathway shortened the length of hospital stay and prevented readmission in patients with acute decompensated heart failure.
    J Cardiol. 2022 Apr 12. pii: S0914-5087(22)00074.
    PubMed     Abstract available


    March 2022
  5. IWANO H, Utsunomiya H, Shibayama K, Tanaka H, et al
    Results of PRospect trial to Elucidate the utility of EchocarDiography-based Cardiac ouTput in acute heart failure (PREDICT).
    J Cardiol. 2022 Mar 17. pii: S0914-5087(22)00055.
    PubMed     Abstract available


  6. NAKAI T, Ikeya Y, Kogawa R, Okumura Y, et al
    Cardiac resynchronization therapy: Current status and near-future prospects.
    J Cardiol. 2022;79:352-357.
    PubMed     Abstract available


  7. OKI T, Ishii S, Takigami Y, Eda Y, et al
    Re-worsening left ventricular ejection fraction after response to cardiac resynchronization therapy.
    J Cardiol. 2022;79:358-364.
    PubMed     Abstract available


    February 2022
  8. YOSHIKAWA T
    New paradigm shift in the pharmacotherapy for heart failure-where are we now and where are we heading?
    J Cardiol. 2022 Feb 25. pii: S0914-5087(22)00031.
    PubMed     Abstract available


  9. SATO Y, Yoshihisa A, Takeishi R, Ohara H, et al
    B-type natriuretic peptide is associated with the occurrence of bleeding events in heart failure patients with a history of coronary artery disease.
    J Cardiol. 2022 Feb 22. pii: S0914-5087(22)00026.
    PubMed     Abstract available


  10. KIDA K, Nabeta T, Ishida M, Shiono T, et al
    D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban.
    J Cardiol. 2022 Feb 8. pii: S0914-5087(22)00015.
    PubMed     Abstract available


    January 2022
  11. MIYANAGA S, Komukai K, Kubota T, Shirasaki K, et al
    Cancer and malnutrition were independently associated with a poor prognosis in patients with heart failure.
    J Cardiol. 2022;79:15-20.
    PubMed     Abstract available


  12. WANG S, Jiang C, Zhao L, Sun S, et al
    Metabolic maturation during postnatal right ventricular development switches to heart-contraction regulation due to volume overload.
    J Cardiol. 2022;79:110-120.
    PubMed     Abstract available


  13. BRONS M, Rutten FH, Zuithoff NPA, Oerlemans MIFJ, et al
    Disease management with home telemonitoring aimed at substitution of usual care in the Netherlands: Post-hoc analyses of the e-Vita HF study.
    J Cardiol. 2022;79:1-5.
    PubMed     Abstract available


    December 2021
  14. YAKU H, Kaneda K, Kitamura J, Kato T, et al
    Kampo medicine for the holistic approach to older adults with heart failure.
    J Cardiol. 2021 Dec 30. pii: S0914-5087(21)00366.
    PubMed     Abstract available


  15. KAKUTANI N, Yokota T, Fukushima A, Obata Y, et al
    Impact of citrus fruit intake on the mental health of patients with chronic heart failure.
    J Cardiol. 2021 Dec 23. pii: S0914-5087(21)00359.
    PubMed     Abstract available


  16. SHINOMIYA H, Koyama S, Tanada Y, Takahashi N, et al
    Corrigendum to "Left ventricular end-diastolic pressure and ejection fraction correlate independently with high-sensitivity cardiac troponin-T concentrations in stable heart failure" 65 (2015) 526-530 6.
    J Cardiol. 2021 Dec 22. pii: S0914-5087(21)00317.
    PubMed    


  17. FUKATA M, Yamasaki H, Sai E, Ogawa K, et al
    Impact of adaptive cardiac resynchronization therapy in patients with systolic heart failure: Beyond QRS duration and morphology.
    J Cardiol. 2021 Dec 19. pii: S0914-5087(21)00315.
    PubMed     Abstract available


  18. SAITO C, Jujo K, Kametani M, Arai K, et al
    Prognostic impact of right ventricular function affected by pulmonary hypertension in hospitalized heart failure patients.
    J Cardiol. 2021 Dec 18. pii: S0914-5087(21)00279.
    PubMed     Abstract available


  19. SAKU K, Yokota S, Nishikawa T, Kinugawa K, et al
    Interventional heart failure therapy: A new concept fighting against heart failure.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00339.
    PubMed     Abstract available


  20. ODAJIMA S, Tanaka H, Fujimoto W, Kuroda K, et al
    Efficacy of Renin-angiotensin-aldosterone-system inhibitors for heart failure with preserved ejection fraction and left ventricular hypertrophy -from the KUNIUMI Registry Acute Cohort.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00357.
    PubMed     Abstract available


  21. MINATOGUCHI S
    Heart failure and its treatment from the perspective of sympathetic nerve activity.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00337.
    PubMed     Abstract available


  22. YAMAMOTO M, Ishizu T, Seo Y, Nakagawa D, et al
    Pathophysiological role of right ventricular function and interventricular functional mismatch in the development of pulmonary edema in acute heart failure.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00342.
    PubMed     Abstract available


  23. NISHIDA H, Ota T, Onsager D, Grinstein J, et al
    Ten-year, single center experience of ambulatory axillary intra-aortic balloon pump support for heart failure.
    J Cardiol. 2021 Dec 8. pii: S0914-5087(21)00320.
    PubMed     Abstract available


  24. OISHI H, Okumura T, Ohashi K, Kimura Y, et al
    Prognostic impact of transcardiac gradient of follistatin-like 1 reflecting hemodynamics in patients with dilated cardiomyopathy.
    J Cardiol. 2021;78:524-532.
    PubMed     Abstract available


    November 2021
  25. HARADA T, Kagami K, Kato T, Obokata M, et al
    Echocardiography in the diagnostic evaluation and phenotyping of heart failure with preserved ejection fraction.
    J Cardiol. 2021 Nov 29. pii: S0914-5087(21)00313.
    PubMed     Abstract available


  26. YAMASHITA M, Kamiya K, Hamazaki N, Nozaki K, et al
    Work status before admission relates to prognosis in older patients with heart failure partly through social frailty.
    J Cardiol. 2021 Nov 21. pii: S0914-5087(21)00307.
    PubMed     Abstract available


  27. NAKAO Y, Kawakami H, Saito M, Inoue K, et al
    Cost-Effectiveness of long-term tolvaptan administration for chronic heart failure treatment in Japan.
    J Cardiol. 2021 Nov 16. pii: S0914-5087(21)00287.
    PubMed     Abstract available


  28. TSAI YL, Chou RH, Lu YW, Chang CC, et al
    Associations between galectin-1, left ventricular diastolic dysfunction, and heart failure with preserved ejection fraction.
    J Cardiol. 2021 Nov 10. pii: S0914-5087(21)00258.
    PubMed     Abstract available


    October 2021
  29. OKADA M, Inoue K
    Catheter ablation of atrial fibrillation with left ventricular systolic dysfunction: Potential approach to the cause of heart failure-authors' reply.
    J Cardiol. 2021;78:347-348.
    PubMed    


    September 2021
  30. IWAHASHI N, Kirigaya J, Abe T, Horii M, et al
    Clinical usefulness of left ventricular outflow tract velocity time integral for heart failure with reduced ejection fraction with rapid atrial fibrillation during landiolol treatment.
    J Cardiol. 2021 Sep 23. pii: S0914-5087(21)00242.
    PubMed     Abstract available


    August 2021
  31. KONISHI M, Akiyama E, Shibata A, Kida K, et al
    Moderate potassium lowering effect of exogenous atrial natriuretic peptide in patients with acute heart failure.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00197.
    PubMed     Abstract available


  32. KANAI M, Yagishita D, Shoda M, Ejima K, et al
    Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00195.
    PubMed     Abstract available


    June 2021
  33. YAMADA T, Haruki S, Minami Y, Numata M, et al
    The C-reactive protein to prealbumin ratio on admission and its relationship with outcome in patients hospitalized for acute heart failure.
    J Cardiol. 2021 Jun 10. pii: S0914-5087(21)00131.
    PubMed     Abstract available


  34. YANAGIHARA K, Kinugasa Y, Kunimi T, Kaneko S, et al
    Child ego state and self-care behavior change in heart failure patients.
    J Cardiol. 2021 Jun 2. pii: S0914-5087(21)00128.
    PubMed     Abstract available


  35. NISHIKIMI T, Nakagawa Y
    Potential pitfalls when interpreting plasma BNP levels in heart failure practice.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00114.
    PubMed     Abstract available


  36. TOMII D, Horiuchi Y, Gonda Y, Yoshiura D, et al
    The role of the renal resistance index in patients with heart failure with reduced or preserved ejection fraction.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00130.
    PubMed     Abstract available


    May 2021
  37. TSAI YN, Cheng WH, Chang YT, Hsiao YW, et al
    Mechanism of angiotensin receptor-neprilysin inhibitor in suppression of ventricular arrhythmia.
    J Cardiol. 2021 May 28. pii: S0914-5087(21)00108.
    PubMed     Abstract available


  38. HITOMI Y, Nagatomo Y, Yukino M, Yumita Y, et al
    Characterization of tolvaptan response and its impact on the outcome for patients with heart failure.
    J Cardiol. 2021 May 23. pii: S0914-5087(21)00111.
    PubMed     Abstract available


    April 2021
  39. MARUYAMA M, Yasuoka R, Nagano T, Nakazawa G, et al
    Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study.
    J Cardiol. 2021 Apr 30. pii: S0914-5087(21)00091.
    PubMed     Abstract available


  40. NAKAMURA T, Tsujita K
    Current trends and future perspectives for heart failure treatment leveraging cGMP modifiers and the practical effector PKG.
    J Cardiol. 2021 Apr 1. pii: S0914-5087(21)00059.
    PubMed     Abstract available


  41. NAKAJIMA DOI S, Seguchi O, Yamamoto M, Fujita T, et al
    Impact of bridge-to-bridge strategies from paracorporeal to implantable left ventricular assist devices on the pre-heart transplant outcome: A single-center analysis of 134 cases.
    J Cardiol. 2021;77:408-416.
    PubMed     Abstract available


    March 2021
  42. YOKOYAMA H, Shishido K, Tobita K, Moriyama N, et al
    Impact of age on mid-term clinical outcomes and left ventricular reverse remodeling after cardiac resynchronization therapy.
    J Cardiol. 2021;77:254-262.
    PubMed     Abstract available


  43. DAYANAND S, Martinez JM, Figueredo VM, Gupta S, et al
    Mechanical Circulatory Support in Women.
    J Cardiol. 2021;77:209-216.
    PubMed     Abstract available


    February 2021
  44. MAEMURA K, Ikeda Y, Oki T, Yazaki M, et al
    Clinical significance of ischemia-like electrocardiographic finding during heart failure treatment on left ventricular recovery in patients with non-ischemic dilated cardiomyopathy.
    J Cardiol. 2021 Feb 19. pii: S0914-5087(21)00037.
    PubMed     Abstract available


  45. KIKUCHI A, Taniguchi T, Nakamoto K, Sera F, et al
    Feasibility of home-based cardiac rehabilitation using an integrated telerehabilitation platform in elderly patients with heart failure: A pilot study.
    J Cardiol. 2021 Feb 10. pii: S0914-5087(21)00023.
    PubMed     Abstract available


  46. SOEDA T, Okura H, Saito Y, Nakao K, et al
    Clinical characteristics and in-hospital outcomes in patients aged 80 years or over with cardiac troponin-positive acute myocardial infarction -J-MINUET study.
    J Cardiol. 2021;77:139-146.
    PubMed     Abstract available


  47. NAITO Y, Masuyama T, Ishihara M
    Iron and cardiovascular diseases.
    J Cardiol. 2021;77:160-165.
    PubMed     Abstract available


    January 2021
  48. FUJIMOTO W, Konishi A, Iwasaki M, Toh R, et al
    Precipitating factors and clinical impact of early rehospitalization for heart failure in patients with heart failure in Awaji Island, Japan.
    J Cardiol. 2021 Jan 5. pii: S0914-5087(20)30418.
    PubMed     Abstract available


  49. SHIINA Y, Nagao M, Shimomiya Y, Inai K, et al
    Secondary sarcopenia assessed by computed tomography can predict hospitalization for heart failure in adults with Fontan circulation.
    J Cardiol. 2021;77:10-16.
    PubMed     Abstract available


  50. KANAMORI H, Naruse G, Yoshida A, Minatoguchi S, et al
    Morphological characteristics in diabetic cardiomyopathy associated with autophagy.
    J Cardiol. 2021;77:30-40.
    PubMed     Abstract available


    December 2020
  51. TANAKA H, Yamauchi Y, Imanishi J, Hatani Y, et al
    Effect of ivabradine on left ventricular diastolic function of patients with heart failure with preserved ejection fraction -IVA-PEF study.
    J Cardiol. 2020 Dec 31. pii: S0914-5087(20)30417.
    PubMed     Abstract available


  52. NATANZON SS, Mazin I
    Author's reply: The outcome of acute decompensated heart failure stratified by the Norton scale on admission.
    J Cardiol. 2020 Dec 4. pii: S0914-5087(20)30385.
    PubMed    


  53. IZUMIDA T, Imamura T
    The outcome of acute decompensated heart failure stratified by the Norton scale on admission.
    J Cardiol. 2020 Dec 3. pii: S0914-5087(20)30386.
    PubMed    


  54. IZUMIDA T, Imamura T
    Sarcopenia in patients with cardiovascular disease.
    J Cardiol. 2020;76:636.
    PubMed    


    November 2020
  55. KURODA S, Mizukami A, Hiroki J, Shimizu Y, et al
    Clinical impact of serial change in brain natriuretic peptide before and after catheter ablation in patients with atrial fibrillation and heart failure.
    J Cardiol. 2020 Nov 25. pii: S0914-5087(20)30374.
    PubMed     Abstract available


  56. CHANG WT, Lin CH, Hong CS, Liao CT, et al
    The predictive value of global longitudinal strain in patients with heart failure mid-range ejection fraction.
    J Cardiol. 2020 Nov 21. pii: S0914-5087(20)30359.
    PubMed     Abstract available


  57. HATA R, Kato T, Yaku H, Morimoto T, et al
    Implantable Cardioverter Defibrillator Therapy in Patients with Acute Decompensated Heart Failure with Reduced Ejection Fraction: An Observation from the KCHF Registry.
    J Cardiol. 2020 Nov 12. pii: S0914-5087(20)30339.
    PubMed     Abstract available


    October 2020
  58. MIRO O, Lopez-Diez MP, Rossello X, Gil V, et al
    Analysis of standards of quality for outcomes in acute heart failure patients directly discharged home from emergency departments and their relationship with the emergency department direct discharge rate.
    J Cardiol. 2020 Oct 11. pii: S0914-5087(20)30307.
    PubMed     Abstract available


    September 2020
  59. KIMURA M, Kohno T, Sawano M, Heidenreich PA, et al
    Independent and cumulative association of clinical and morphological heart failure with long-term outcome after percutaneous coronary intervention.
    J Cardiol. 2020 Sep 1. pii: S0914-5087(20)30208.
    PubMed     Abstract available


  60. KOBAYASHI S, Yoshiga Y, Yano M
    Author's reply: The RyR2 - Targeting therapy against lethal arrhythmia.
    J Cardiol. 2020;76:323-324.
    PubMed    


    August 2020
  61. KWAK S, Kwon S, Lee SY, Yang S, et al
    Differential risk of incident cancer in patients with heart failure: A nationwide population-based cohort study.
    J Cardiol. 2020 Aug 28. pii: S0914-5087(20)30271.
    PubMed     Abstract available


  62. MIZOBUCHI A, Osawa K, Tanaka M, Yumoto A, et al
    Detrended fluctuation analysis can detect the impairment of heart rate regulation in patients with heart failure with preserved ejection fraction.
    J Cardiol. 2020 Aug 18. pii: S0914-5087(20)30274.
    PubMed     Abstract available


  63. TOPAZ G, Yehezkel E, Benchetrit S, Korzets Z, et al
    Non-coronary cardiac calcifications and outcomes in patients with heart failure.
    J Cardiol. 2020 Aug 18. pii: S0914-5087(20)30261.
    PubMed     Abstract available


  64. NAKANE E, Kato T, Tanaka N, Kuriyama T, et al
    Association of the induction of a self-care management system with 1-year outcomes in patients hospitalized for heart failure.
    J Cardiol. 2020 Aug 2. pii: S0914-5087(20)30257.
    PubMed     Abstract available


    July 2020
  65. CAFFREY JL, Wu CK, Chang CH, Lin JW, et al
    Analysis of mortality risk following receipt of implantable cardioverter defibrillators in patients with and without heart failure.
    J Cardiol. 2020 Jul 15. pii: S0914-5087(20)30184.
    PubMed     Abstract available


  66. PHAM VT, Lin C, Tran TT, M Su MY, et al
    Predicting ventricular tachyarrhythmia in patients with systolic heart failure based on texture features of the gray zone from contrast-enhanced magnetic resonance imaging.
    J Cardiol. 2020 Jul 13. pii: S0914-5087(20)30222.
    PubMed     Abstract available


  67. TAKAGI K, Sato N, Ishihara S, Iha H, et al
    Differences in pharmacological property between combined therapy of the vasopressin V2-receptor antagonist tolvaptan plus furosemide and monotherapy of furosemide in patients with hospitalized heart failure.
    J Cardiol. 2020 Jul 11. pii: S0914-5087(20)30172.
    PubMed     Abstract available


  68. MITANI H, Funakubo M, Sato N, Murayama H, et al
    In-hospital resource utilization, worsening heart failure, and factors associated with length of hospital stay in patients with hospitalized heart failure: A Japanese database cohort study.
    J Cardiol. 2020 Jul 4. pii: S0914-5087(20)30173.
    PubMed     Abstract available


  69. SAITO H, Yamashita M, Endo Y, Mizukami A, et al
    Cognitive impairment measured by Mini-Cog provides additive prognostic information in elderly patients with heart failure.
    J Cardiol. 2020 Jul 2. pii: S0914-5087(20)30210.
    PubMed     Abstract available


    June 2020
  70. NATANZON SS, Maor E, Klempfner R, Goldenberg I, et al
    Norton score and clinical outcomes following acute decompensated heart failure hospitalization.
    J Cardiol. 2020 Jun 10. pii: S0914-5087(20)30178.
    PubMed     Abstract available


    May 2020
  71. HARADA D, Asanoi H, Noto T, Takagawa J, et al
    The impact of right ventricular dysfunction on the effectiveness of beta-blockers in heart failure with preserved ejection fraction.
    J Cardiol. 2020 May 28. pii: S0914-5087(20)30163.
    PubMed     Abstract available


  72. SATO K, Takahashi J, Hao K, Miyata S, et al
    Temporal trends in the prevalence and outcomes of geriatric patients with acute myocardial infarction in Japan-A report from the Miyagi AMI Registry Study.
    J Cardiol. 2020;75:465-472.
    PubMed     Abstract available


    April 2020
  73. NAKAGAWA Y, Kuwahara K
    Sodium-Glucose Cotransporter-2 inhibitors are potential therapeutic agents for treatment of non-diabetic heart failure patients.
    J Cardiol. 2020 Apr 24. pii: S0914-5087(20)30122.
    PubMed     Abstract available


  74. SPARTALIS M, Iliopoulos DC, Spartalis E, Athanasiou A, et al
    The genesis of ventricular arrhythmias in heart failure patients is based on alterations in cardiac mechanical, morphological, metabolic, electrophysiological properties, and neurohumoral remodeling.
    J Cardiol. 2020 Apr 22. pii: S0914-5087(20)30104.
    PubMed    


  75. YAMAMOTO S, Yamaga T, Nishie K, Sakai Y, et al
    Impact of physical performance on prognosis among patients with heart failure: Systematic review and meta-analysis.
    J Cardiol. 2020 Apr 11. pii: S0914-5087(20)30094.
    PubMed     Abstract available


  76. TAKAGI K, Ishihara S, Kenji N, Iha H, et al
    Clinical significance of arterial stiffness as a factor for hospitalization of heart failure with preserved left ventricular ejection fraction: a retrospective matched case-control study.
    J Cardiol. 2020 Apr 5. pii: S0914-5087(20)30069.
    PubMed     Abstract available


  77. KODZISZEWSKA K, Sochanowicz B, Smigielski W, Kruszewski M, et al
    Grey areas and open questions in neprilysin inhibition.
    J Cardiol. 2020;75:462-463.
    PubMed    


  78. CHANG HY, Yin WH
    Response to "Grey Areas and Open Questions in Neprilysin Inhibition".
    J Cardiol. 2020;75:463-464.
    PubMed    


  79. LIANG Y, Wang J, Yu Z, Zhang M, et al
    Comparison between cardiac resynchronization therapy with and without defibrillator on long-term mortality: A propensity score matched analysis.
    J Cardiol. 2020;75:432-438.
    PubMed     Abstract available


    March 2020
  80. SUZUKI A, Shiga T, Kawashiro N, Hagiwara N, et al
    Changes in characteristics and outcomes in Japanese patients with heart failure from the 2000s to the 2010s: The HIJ-HF cohorts.
    J Cardiol. 2020 Mar 18. pii: S0914-5087(20)30064.
    PubMed     Abstract available


  81. CHANG HY, Chen KC, Fong MC, Feng AN, et al
    Recovery of left ventricular dysfunction after sacubitril/valsartan: predictors and management.
    J Cardiol. 2020;75:233-241.
    PubMed     Abstract available


    February 2020
  82. SPARTALIS M, Iliopoulos DC, Spartalis E, Athanasiou A, et al
    Is the clinical benefit of implantable cardioverter-defibrillators in heart failure patients declining?
    J Cardiol. 2020 Feb 27. pii: S0914-5087(20)30045.
    PubMed    


  83. DISERTORI M, Mase M, Rigoni M, Nollo G, et al
    Author's reply: "Declining clinical benefit of ICD in heart failure patients".
    J Cardiol. 2020 Feb 22. pii: S0914-5087(20)30038.
    PubMed    


  84. NISTRI S, Mazzone C, Cioffi G, Barbati G, et al
    Tissue Doppler indices of diastolic function as prognosticator in patients without heart failure in primary care.
    J Cardiol. 2020 Feb 21. pii: S0914-5087(20)30034.
    PubMed     Abstract available


  85. KAWAGUCHI J, Hamatani Y, Hirayama A, Nishimura K, et al
    Experience of morphine therapy for refractory dyspnea as palliative care in advanced heart failure patients.
    J Cardiol. 2020 Feb 12. pii: S0914-5087(20)30016.
    PubMed     Abstract available


    January 2020
  86. NAKANO I, Tsuda M, Kinugawa S, Fukushima A, et al
    Loop diuretic use is associated with skeletal muscle wasting in patients with heart failure.
    J Cardiol. 2020 Jan 27. pii: S0914-5087(20)30018.
    PubMed     Abstract available


  87. HIRAIWA H, Okumura T, Kondo T, Kato T, et al
    Usefulness of the plasma branched-chain amino acid/aromatic amino acid ratio for predicting future cardiac events in patients with heart failure.
    J Cardiol. 2020 Jan 27. pii: S0914-5087(20)30017.
    PubMed     Abstract available


    December 2019
  88. NOZAKI K, Hamazaki N, Kamiya K, Ichikawa T, et al
    Rising time from bed in acute phase after hospitalization predicts frailty at hospital discharge in patients with acute heart failure.
    J Cardiol. 2019 Dec 30. pii: S0914-5087(19)30381.
    PubMed     Abstract available


  89. KAGIYAMA Y, Yatsuga S, Kinoshita M, Koteda Y, et al
    Growth differentiation factor 15 as a useful biomarker of heart failure in young patients with unrepaired congenital heart disease of left to right shunt.
    J Cardiol. 2019 Dec 26. pii: S0914-5087(19)30382.
    PubMed     Abstract available


  90. KOBAYASHI S, Wakeyama T, Ono S, Ikeda Y, et al
    A multicenter, randomized, double-blind, controlled study to evaluate the efficacy and safety of dantrolene on ventricular arrhythmia as well as mortality and morbidity in patients with chronic heart failure (SHO-IN trial): rationale and design.
    J Cardiol. 2019 Dec 19. pii: S0914-5087(19)30282.
    PubMed     Abstract available


    November 2019
  91. MAEJIMA Y
    The critical roles of protein quality control systems in the pathogenesis of heart failure.
    J Cardiol. 2019 Nov 4. pii: S0914-5087(19)30318.
    PubMed     Abstract available


    October 2019
  92. KONISHI M, Matsuzawa Y, Ebina T, Kosuge M, et al
    Impact of population density on mortality in patients hospitalized for heart failure - JROAD-DPC Registry Analysis.
    J Cardiol. 2019 Oct 9. pii: S0914-5087(19)30298.
    PubMed     Abstract available


    September 2019
  93. HAYASHI H, Abe Y, Morita Y, Yamaji Y, et al
    Prognostic significance of moderate primary mitral regurgitation and concomitant paroxysmal atrial fibrillation.
    J Cardiol. 2019 Sep 12. pii: S0914-5087(19)30276.
    PubMed     Abstract available


  94. YAMASAKI H, Sekiguchi Y, Gosho M, Nogami A, et al
    Design and results of aCRT MID-Q study: Adoption of adaptive CRT in patients with normal AV conduction and moderately wide left bundle branch block.
    J Cardiol. 2019 Sep 3. pii: S0914-5087(19)30262.
    PubMed     Abstract available


    May 2019
  95. GOURRONC Y, Grall S, Ingremeau D, Desprets L, et al
    De novo atrial fibrillation as an independent prognostic marker after ST-segment elevation myocardial infarction: Results from the RIMA registry.
    J Cardiol. 2019 May 9. pii: S0914-5087(19)30040.
    PubMed     Abstract available


  96. NAKASHIMA A, Miyoshi T, Aoki-Kamiya C, Nishio M, et al
    Predicting postpartum cardiac events in pregnant women with complete atrioventricular block.
    J Cardiol. 2019 May 3. pii: S0914-5087(19)30099.
    PubMed     Abstract available


    April 2019
  97. FERRI-CERTIC J, Zavrl-Dzananovic D, Lezaic L, Zizek D, et al
    Impact of left ventricular pacing threshold on ventricular arrhythmia occurrence in cardiac resynchronization therapy.
    J Cardiol. 2019 Apr 13. pii: S0914-5087(19)30087.
    PubMed     Abstract available


    February 2019
  98. KITAOKA H
    Author's reply.
    J Cardiol. 2019;73:186.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: